Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Saroja Pharma Industries India Ltd.

NSE: SAROJA | BSE:

₹58.30 0.05 (0.09%) 1D

Chemicals & Petrochemicals

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

58.30

Today’s High

58.50

52W low

33.10

52W High

82.90

Open Price

58.50

Prev. Close

62.7000

Volume

4800.00

Value

279840.00

Fundamentals

Market Cap

23.40

Price to Earnings

0.00

Price to Book Value

1.60

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

1.02

Return on Equity %

5.99

EMA & SMA

Bullish Moving Averages

9

Bearish Moving Averages

5

5Day EMA

60.1

10Day EMA

59.6

12Day EMA

59

20Day EMA

56.7

26Day EMA

55.1

50Day EMA

51.3

100Day EMA

49.7

EMA

5Day SMA

61.5

10Day SMA

61.8

20Day SMA

55.8

30Day SMA

52.6

50Day SMA

48.7

100Day SMA

45.4

150Day SMA

47.7

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Sep, 2024

100

Week

85.7

Month

66.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

58.58

PIVOT

First Resistance

58.92

Second Resistance

59.58

Third Resistance

59.92

First Support

57.92

Second Support

57.58

Third Support

56.92

Relative Strength Index

55.58

Money Flow Index

78.65

MACD

3.92

MACD Signal

4.05

Average True Range

2.97

Average Directional Index

26.5

Rate of Change (21)

22.63

Rate of Change (125)

9.91

Day Commodity Channel Index

28.9

Day Williams %R

-48.6

BETA

1 Month

-4.58

3 Month

-0.92

1 Year

3 Year

PRICE CHANGE ANALYSIS

↑ 0.52%

1 Week

Low

High

58.25

65

↑ 22.74%

1 Month

Low

High

45.05

70.75

↑ 45.21%

3 Months

Low

High

40.95

70.75

↑ 45.39%

6 Months

Low

High

33.1

70.75

↓ -26.16%

1 Year

Low

High

33.1

82.9

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 40.86 50.35 55.96 36.75 17.09
Operating Expenses Annual Cr 38.12 47.47 53.53 35.40 16.71
Operating Profit Annual 2.55 2.72 2.10 1.26 0.37
Operating Profit Margin Annual % 6.25 5.40 3.76 3.44 2.18
Total Expenses Annual Cr 39.66 48.86 54.38 35.71 16.87
EBIDT Annual Cr 2.75 2.88 2.43 1.35 0.38
EBIDT Annual margin % 6.72 5.71 4.34 3.67 2.22
Depreciation 0.09 0.07 0.05 0.02 0.00
PAT Before ExtraOrdinary Items Annual Cr 0.88 1.06 1.14 0.73 0.16
Net Profit Annual 0.88 1.06 1.14 0.73 0.16
Basic EPS Annual 2.49 17.55 68.72 731.30 160.93
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 14.64 5.09 4.03 0.94 0.20
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 2.63 2.82 1.70 0.00 0.00
Total Current Liabilities Annual Cr 9.29 13.43 9.79 7.29 4.61
Total Capital Plus Liabilities Annual Cr 26.56 21.34 15.51 8.22 4.82
Fixed Assets Annual 8.64 4.00 0.34 0.09 0.06
Total Non Current Assets Annual 8.96 5.19 0.42 0.09 0.06
Total Current Assets Annual 17.60 16.15 15.09 8.13 4.76
Total Assets Annual 26.56 21.34 15.51 8.22 4.82
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 1.02 2.19 -3.67 -1.09 -0.89
Cash from Investing Activity Annual -4.76 -4.82 -0.34 -0.05 -0.02
Cash from Financing Annual Activity 3.70 2.73 4.27 1.06 0.97
Net Cash Flow Annual -0.04 0.10 0.26 -0.07 0.06
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 36.42 17.33 178.28 935.94 204.63
ROE Annual % 5.99 20.85 28.31 78.13 78.64
ROCE Annual % 15.36 35.52 41.57 141.36 182.96
Total Debt to Total Equity Annual 0.39 2.00 1.52 3.22 8.39
EBDIT Annual Margin % 6.75 5.73 4.36 3.67 2.21
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Graph
Total Revenue Annual
Operating Expenses Annual Cr
Operating Profit Annual
Operating Profit Margin Annual %
Total Expenses Annual Cr
EBIDT Annual Cr
EBIDT Annual margin %
Depreciation
PAT Before ExtraOrdinary Items Annual Cr
Net Profit Annual
Basic EPS Annual
Indicator Graph
Total ShareHolders Funds Annual
Minority Interest Liability Annual Cr
Total Non Current Liabilities Annual Cr
Total Current Liabilities Annual Cr
Total Capital Plus Liabilities Annual Cr
Fixed Assets Annual
Total Non Current Assets Annual
Total Current Assets Annual
Total Assets Annual
Contingent Liabilities plus Commitments Annual Cr
Indicator Graph
Cash from Operating Activity Annual
Cash from Investing Activity Annual
Cash from Financing Annual Activity
Net Cash Flow Annual
Indicator Graph
Book Value Per Share Annual
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual
EBDIT Annual Margin %
Name Holding Percent Holding Id Pledged % Locked %
SWASTIKA INVESTMART LTD 1.39 75290231 - -
Name Holding Percent Holding Id Pledged % Locked %
BIJU GOPINATHAN NAIR 72.05 75290217 0 100
MANISH DASHARATH KAMBLE 0.97 75290222 0 100
Name Holding Percent Holding Id
Name Holding Percent Holding Id
KAMLESH NATWARLAL SHAH 1.31 75290228
HUF 1.03 75290233
SWASTIKA INVESTMART LTD 1.39 75290231
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 29, 2024 Audited Results -
Ex-Date Bonus Ratio Record Date
08 Sep 2023

Saroja Pharma IPO allotment: Latest GMP, here's how to check allotment status

 Saroja Pharma IPO allotment date: Saroja Pharma Industries IPO share allotment will be finalised today.
See all News

FAQs

The latest market price of Saroja Pharma Industries India Ltd. on NSE was Rs. 58.30 as of today.

The opening share price of Saroja Pharma Industries India Ltd. was Rs. 58.50 as of today.

The 52-week high share price of Saroja Pharma Industries India Ltd. was Rs. 82.90.

The 52 week low share price of Saroja Pharma Industries India Ltd. was Rs. 33.10.

Please find Corporate actions section for more details.

The PE ratio of Saroja Pharma Industries India Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Saroja Pharma Industries India Ltd..

Close

Let's Open Free Demat Account